Persistent tunica vasculosa lentis
Persistent tunica vasculosa lentis (PTVL) is a rare ophthalmological condition characterized by the incomplete regression of the tunica vasculosa lentis, a vascular network that supplies the developing lens of the eye during embryogenesis. This condition can lead to various visual impairments, including cataracts, glaucoma, and microphthalmia.
Etiology[edit | edit source]
The exact cause of PTVL is not well understood. It is believed to be associated with genetic factors, as it has been observed in certain familial clusters. Some researchers suggest that it may be linked to mutations in the FOXE3 gene, which plays a crucial role in eye development.
Pathophysiology[edit | edit source]
During normal embryogenesis, the tunica vasculosa lentis forms to provide nutrients to the developing lens. By the third trimester of pregnancy, this network typically regresses completely. In cases of PTVL, this regression is incomplete, leading to a persistent vascular network that can interfere with the normal development and function of the eye.
Clinical Presentation[edit | edit source]
Patients with PTVL often present with visual disturbances such as blurred vision or decreased visual acuity. Physical examination may reveal a cloudy or opaque lens (cataract), increased intraocular pressure (glaucoma), or a smaller than normal eye (microphthalmia). In severe cases, PTVL can lead to blindness.
Diagnosis[edit | edit source]
Diagnosis of PTVL is typically made based on clinical findings and confirmed with imaging studies such as ultrasonography or MRI. Genetic testing may also be performed to identify potential genetic mutations associated with the condition.
Treatment[edit | edit source]
Treatment for PTVL is primarily aimed at managing the associated conditions and improving visual function. This may include surgical removal of cataracts, medication or surgery to manage glaucoma, and visual rehabilitation therapies.
Prognosis[edit | edit source]
The prognosis for PTVL varies depending on the severity of the condition and the associated visual impairments. With early diagnosis and appropriate treatment, many patients can achieve improved visual function.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD